부산대학교 도서관

Hamy, A.-S. ; Grandal, B. ; Jochum, F. ; Dumas, É. ; Sella, N. ; Kassara, A. ; Barraud, S. ; Dubois, T. ; Ballesta, A. ; Everhard, S. ; Lemonnier, J. ; Sauzey, M. ; Bertaut, A. ; Blay, J.-Y. ; Cottu, P. ; Tredan, O. ; Joly, F. ; Gougis, P. ; Asselain, B. ; Latouche, A. ; Vaz Luis, I. ; Andre, F. ; Reyal, F.

In ESMO Open May 2025 10(5)

Dumas E; Institute of Mathematics, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, Institut National de la Santé et de la Recherche Médicale (INSERM), U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Hamy AS; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, Institut National de la Santé et de la Recherche Médicale (INSERM), U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France.; Wanis KN; Departments of Breast Surgical Oncology and Health Services Research and Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston.; Jochum F; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, Institut National de la Santé et de la Recherche Médicale (INSERM), U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Gynecology, Strasbourg University Hospital, Strasbourg, France.; Coussy F; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, Institut National de la Santé et de la Recherche Médicale (INSERM), U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France.; Giacchetti S; Sénopole, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; Gaillard T; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, Institut National de la Santé et de la Recherche Médicale (INSERM), U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Surgical Oncology, Université Paris Cité, Institut Curie, Paris, France.; Laas E; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, Institut National de la Santé et de la Recherche Médicale (INSERM), U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Surgical Oncology, Université Paris Cité, Institut Curie, Paris, France.; Houzard S; Health Data and Assessment, Health Survey Data Science and Assessment Division, Institut National du Cancer (INCa), Boulogne-Billancourt, France.; Le Bihan-Benjamin C; Health Data and Assessment, Health Survey Data Science and Assessment Division, Institut National du Cancer (INCa), Boulogne-Billancourt, France.; Reyal F; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, Institut National de la Santé et de la Recherche Médicale (INSERM), U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Surgical Oncology, Université Paris Cité, Institut Curie, Paris, France.; Department of Surgery, Institut Jean Godinot, Reims, France.; Gougis P; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, Institut National de la Santé et de la Recherche Médicale (INSERM), U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Medical Oncology, Pitié-Salpêtrière Hospital, Sorbonne Université, Institut Universitaire du Cancer, Paris, France.; Clinical Investigation Center (CIC-1901), INSERM, Department of Pharmacology, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.; Stensrud MJ; Institute of Mathematics, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Mbaye NM; Centre for Computational Biology (CBIO), Mines Paris, Paris Sciences & Lettres (PSL) Research University, Paris, France.; Institut Curie, Paris Sciences & Lettres (PSL) Research University, Paris, France.; U900, Inserm, Paris, France.; Danziger MM; AI for Accelerated Healthcare and Life Sciences Discovery, IBM Research Lab - Israel, Haifa, Israel.; Rosen-Zvi M; AI for Accelerated Healthcare and Life Sciences Discovery, IBM Research Lab - Israel, Haifa, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Toussaint A; Institut Curie, Paris Sciences & Lettres (PSL) Research University, Paris, France.; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.; Dumas E; Centre for Computational Biology (CBIO), Mines Paris, Paris Sciences & Lettres (PSL) Research University, Paris, France.; U900, Inserm, Paris, France.; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.; Guerin J; Data Office, Institut Curie, Paris, France.; Hamy-Petit AS; Institut Curie, Paris Sciences & Lettres (PSL) Research University, Paris, France.; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.; Reyal F; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.; Department of Surgical Oncology, Institut Curie, University of Paris, Paris, France.; Department of Surgery, Institut Jean Godinot, Reims, France.; Azencott CA; Centre for Computational Biology (CBIO), Mines Paris, Paris Sciences & Lettres (PSL) Research University, Paris, France.; Institut Curie, Paris Sciences & Lettres (PSL) Research University, Paris, France.; U900, Inserm, Paris, France.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Naylor, P.; Lae, M.; Reyal, F.; Walter, T.

IEEE Transactions on Medical Imaging IEEE Trans. Med. Imaging Medical Imaging, IEEE Transactions on. 38(2):448-459 Feb, 2019

Talagrand, L.-S. ; Beaulaton, C. ; Smadja, J. ; Rodrigues, M. ; Frank, S. ; Kissel, M. ; Catteau, L. ; Salomon, A. ; Bataillon, G. ; Laas, E. ; Feron, J.-G. ; Fourchotte, V. ; Darrigues, L. ; Osdoit, M. ; Girard, N. ; Reyal, F. ; Lécuru, F.

In EMC - Ginecología-Obstetricia February 2023 59(1):1-16

Laas, E.; Darrigues, L.; Binder, J. -P.; Van-Coppenolle, C.; Fourchotte, V.; Feron, J. -G.; Gaillard, T.; Reyal, F.; Couturaud, B.

ANNALES DE CHIRURGIE PLASTIQUE ESTHETIQUE; NOV 2025, 70 6, p581-p589, 9p.

Taba, G.; Ceccato, V.; Fernandes, O.; Michel, S.; Darrigues, L.; Girard, N.; Gauroy, E.; Pauly, L.; Gaillard, T.; Reyal, F.; Hotton, J.

Journal of Plastic, Reconstructive & Aesthetic Surgery. 85:202-209

Dumas, E.; Hamy-Petit, A-S.; Gougis, P.; Laas, E.; El Ferjaoui, S.; Jochum, F.; Wanis, K. Nashat; Bousquet, P-J.; Houzard, S.; Le Bihan-Benjamin, C.; Reyal, F.; Stensrud, M.J.; Coussy, F.

ESMO Open. 9

Gougis, P. ; Géraud, A. ; Hilmi, M. ; Vozy, A. ; Campedel, L. ; Abbar, B. ; Allio, C. ; De Chatillon, S. ; Portalier, A. ; Lapray, F. ; Choquet, S. ; Spano, J.-P. ; Reyal, F. ; Mir, O. ; Funck-Brentano, C. ; Hamy, A.-S.

In ESMO Open December 2022 7(6)

Lamy C; Department of Drug Development and Innovation (D3i), Paris-Saclay University, Paris, France.; Laurent L; Department of Drug Development and Innovation (D3i), Paris-Saclay University, Paris, France.; Choussy O; Department of Head and Neck Surgery, Institut Curie, Paris, France.; Pouget N; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris and Saint-Cloud, France.; Lecuru F; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris and Saint-Cloud, France.; Reyal F; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris and Saint-Cloud, France.; Plissonnier AS; DREH Pôle Promotion, Institut Curie, Saint-Cloud, France.; Kadi A; Department of Biometry, Institut Curie, Saint-Cloud, France.; Berger F; Department of Biometry, Institut Curie, Saint-Cloud, France.; Martin J; Department of Head and Neck Surgery, Institut Curie, Paris, France.; Dubray-Vautrin A; Department of Head and Neck Surgery, Institut Curie, Paris, France.; Computational Oncology, PSL Research University, Mines Paris Tech, INSERM U1331, Paris, 75005, France.; Marret G; Department of Drug Development and Innovation (D3i), Paris-Saclay University, Paris, France.; Borcoman E; Department of Drug Development and Innovation (D3i), Paris-Saclay University, Paris, France.; Romano E; Department of Drug Development and Innovation (D3i), Paris-Saclay University, Paris, France.; Sablin MP; Department of Drug Development and Innovation (D3i), Paris-Saclay University, Paris, France.; Cabel L; Department of Drug Development and Innovation (D3i), Paris-Saclay University, Paris, France.; Pasquesoone C; Department of Pathology, Oscar Lambret Cancer Centre, Lille, France.; Lantz O; Clinical Immunology Laboratory, Institut Curie, Paris, France.; Centre d'investigation Clinique en Biothérapie Gustave-Roussy Institut Curie (CIC-BT1428), Paris, France.; Louis D; Clinical Immunology Laboratory, Institut Curie, Paris, France.; Centre d'investigation Clinique en Biothérapie Gustave-Roussy Institut Curie (CIC-BT1428), Paris, France.; Gorret D; Clinical Immunology Laboratory, Institut Curie, Paris, France.; Centre d'investigation Clinique en Biothérapie Gustave-Roussy Institut Curie (CIC-BT1428), Paris, France.; Da Silva ID; Clinical Immunology Laboratory, Institut Curie, Paris, France.; Centre d'investigation Clinique en Biothérapie Gustave-Roussy Institut Curie (CIC-BT1428), Paris, France.; Mariani O; Department of Pathology, Centre Des Ressources Biologiques, Institut Curie, Paris, France.; Delattre O; Department of Genetics, Institut Curie, Paris, France.; Bièche I; Department of Genetics, Institut Curie, Paris, France.; Servant N; Computational Oncology, PSL Research University, Mines Paris Tech, INSERM U1331, Paris, 75005, France.; Bioinformatics Platform, Institut Curie, Mines Paris Tech, Paris, France.; Rodrigues M; Department of Medical Oncology, Institut Curie, Paris & Paris Cité, France.; INSERM U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Equipe Labellisée Par la Ligue Nationale Contre Le Cancer, Institut Curie, PSL Research University, Paris, France.; Pierga JY; Department of Medical Oncology, Institut Curie, Paris & Paris Cité, France.; Seban RD; Department of Nuclear Medicine, Institut Curie, Saint-Cloud, 92210, France.; Marangoni E; Translational Research Department, Institute of Curie, Paris, France.; Morillon A; Institut Curie, CNRS UMR3244, Sorbonne University, PSL University, Paris, France.; Théry C; Institut Curie, INSERM U932 and Curie CoreTech Extracellular Vesicles PSL Research University, Paris, France.; Proudhon C; Circulating Tumor Biomarkers Laboratory, SiRIC, Translational Research Department, Institut Curie, PSL Research University, Paris, 75005, France.; Univ Rennes, Inserm, EHESP,, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France.; Piaggio E; Institut Curie, PSL University, Department of Translational Research, Inserm U932, Laboratory of Immunity and Cancer, Paris, F-75005, France.; Vallot C; Institut Curie, CNRS UMR3244, Sorbonne University, PSL University, Paris, France.; Mechta-Grigoriou F; Stress and Cancer Laboratory, Institut Curie, INSERM, U830, PSL Research University, Ligue Nationale Contre le Cancer labeled Team, Paris, France.; Flavius J; Department of Drug Development and Innovation (D3i), Paris-Saclay University, Paris, France.; Dupain C; Department of Drug Development and Innovation (D3i), Paris-Saclay University, Paris, France.; Gentric G; Stress and Cancer Laboratory, Institut Curie, INSERM, U830, PSL Research University, Ligue Nationale Contre le Cancer labeled Team, Paris, France.; Vincent-Salomon A; Department of Pathology, Institut Curie, PSL University, INSERM U934, CNRS UMR 3215, Paris, France.; Kamal M; Department of Drug Development and Innovation (D3i), Paris-Saclay University, Paris, France.; National PRecISion Medicine Center in Oncology, Gustave Roussy Cancer Campus, Paris, France.; Le Tourneau C; Department of Drug Development and Innovation (D3i), Paris-Saclay University, Paris, France. christophe.letourneau@curie.fr.; Computational Oncology, PSL Research University, Mines Paris Tech, INSERM U1331, Paris, 75005, France. christophe.letourneau@curie.fr.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Pellisé-Tintoré M; Institut Curie, 5 Rue d'Ulm, 75005, Paris, France; Dexeus Universitary Hospital, Sabino de Arana 19, 08028, Barcelona, Spain. Electronic address: maria.pellisetintore@gmail.com.; Gaillard T; Institut Curie, 5 Rue d'Ulm, 75005, Paris, France; Université Paris Cité, Paris, France.; Laas E; Institut Curie, 5 Rue d'Ulm, 75005, Paris, France.; Fourchotte V; Institut Curie, 5 Rue d'Ulm, 75005, Paris, France.; Didelot H; Institut Curie, 5 Rue d'Ulm, 75005, Paris, France.; Pauly L; Institut Curie, 5 Rue d'Ulm, 75005, Paris, France.; Feron JG; Institut Curie, 5 Rue d'Ulm, 75005, Paris, France.; Reyal F; Institut Curie, 5 Rue d'Ulm, 75005, Paris, France; Université Paris Cité, Paris, France.; Lecuru F; Institut Curie, 5 Rue d'Ulm, 75005, Paris, France; Université Paris Cité, Paris, France.

Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9208188 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3320 (Electronic) Linking ISSN: 09607404 NLM ISO Abbreviation: Surg Oncol Subsets: MEDLINE

Jochum F; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France.; Dumas É; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Institute of Mathematics, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; Salem JE; Clinical Investigation Center (CIC-1901) INSERM, Department of Pharmacology, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.; Ederhy S; Cardiology Department, Saint-Antoine University Hospital, AP-HP, Paris, France.; Hamy AS; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Department of Medical Oncology, Institut Curie, Paris, France.; Lecointre L; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France.; Laas E; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, France.; Reyal F; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, France.; Department of Surgical Oncology, Institut Godinot, Reims, France.; Lecuru F; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, France.; Akladios C; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France.; Gougis P; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Clinical Investigation Center (CIC-1901) INSERM, Department of Pharmacology, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.; Department of Medical Oncology, Sorbonne Université, Institut Universitaire du Cancer, Pitié-Salpêtrière Hospital, Paris, France.

Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

Hamy AS; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Chabassier A; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Sebbag C; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Rousset-Jablonski C; Centre Léon Bérard, Lyon, France.; RESearch on HealthcAre PErformance (RESHAPE), University Claude Bernard Lyon 1, Lyon, France.; Berkach C; Unité de Génétique Clinique, Hôpital Saint-Louis, APHP, France.; Ray-Coquard I; Centre Léon Bérard, Lyon, France.; RESearch on HealthcAre PErformance (RESHAPE), University Claude Bernard Lyon 1, Lyon, France.; Sablone L; Seintinelles Research Network, 40 Rue Rémy Dumoncel, Paris, 75014, France.; Darrigues L; Department of Surgical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Dumas E; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Bobrie A; Department of Medical Oncology, Institut du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France.; Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France.; Espié M; Sénopole, Hôpital Saint-Louis, AP-HP, Paris, France.; Université Paris Cité, Paris, France.; Giacchetti S; Sénopole, Hôpital Saint-Louis, AP-HP, Paris, France.; Université Paris Cité, Paris, France.; Jochum F; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Gynecology, Strasbourg University Hospital, Strasbourg, France.; Toussaint A; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Plu-Bureau G; Department of Gynecology, Hôpital Cochin, Paris, France.; Université Paris Cité, Paris, France.; Maitrot-Mantelet L; Department of Gynecology, Hôpital Cochin, Paris, France.; Université Paris Cité, Paris, France.; Gompel A; Department of Gynecology, Hôpital Cochin, Paris, France.; Université Paris Cité, Paris, France.; Gougis P; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Sorbonne Université, INSERM, UNICO-GRECO Cardio-oncology Program, Department of Pharmacology, GRC27, CIC-1901, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.; Bas R; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Decanter C; ART Department, Centre Hospitalier Régional Lille, Lille, France.; Asselain B; Department of Biostatistics, Unicancer, Paris, France.; Coutant C; Clinical Research Department, Centre Georges-François Leclerc (Unicancer), Dijon, France.; Sohn L; Seintinelles Research Network, 40 Rue Rémy Dumoncel, Paris, 75014, France.; Jacob G; Seintinelles Research Network, 40 Rue Rémy Dumoncel, Paris, 75014, France.; Saule C; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Frank S; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Abécassis J; Project-team Soda, Inria Saclay, Palaiseau, France.; Institut Polytechnique de Paris, Palaiseau, France.; Coussy F; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Reyal F; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Surgical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.

Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

Mukhtar RA; University of California San Francisco, San Francisco, USA. Rita.Mukhtar@ucsf.edu.; Gottipati S; University of California San Francisco, San Francisco, USA.; Yau C; University of California San Francisco, San Francisco, USA.; López-Tarruella S; Instituto de Investigación Sanitaria Gregorio Marañón Madrid, Madrid, Spain.; Earl H; University of Cambridge, Cambridge, UK.; Hayward L; Western General Hospital, Edinburgh, UK.; Hiller L; University of Warwick, Coventry, UK.; Osdoit M; Institut Curie, Paris, France.; van der Noordaa M; Université de Rouen, Rouen, France.; de Croze D; Institut Curie, Paris, France.; Hamy AS; Institut Curie, Paris, France.; Laé M; Institut Curie, Paris, France.; Université de Rouen, Rouen, France.; Reyal F; Institut Curie, Paris, France.; Sonke GS; Netherlands Cancer Institute, Amsterdam, The Netherlands.; Steenbruggen TG; Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Seijen M; Netherlands Cancer Institute, Amsterdam, The Netherlands.; Wesseling J; Netherlands Cancer Institute, Amsterdam, The Netherlands.; Martín M; Instituto de Investigación Sanitaria Gregorio Marañón Madrid, Madrid, Spain.; Del Monte-Millán M; Instituto de Investigación Sanitaria Gregorio Marañón Madrid, Madrid, Spain.; Boughey JC; Mayo Clinic, Rochester, USA.; Goetz MP; Mayo Clinic, Rochester, USA.; Hoskin T; Mayo Clinic, Rochester, USA.; Valero V; University of Texas MD Anderson Cancer Center, Houston, USA.; Edge SB; Roswell Park Cancer Institute, Buffalo, USA.; Abraham JE; University of Cambridge, Cambridge, UK.; Bartlett JMS; Ontario Institute for Cancer Research, Toronto, Canada.; Edinburgh Cancer Research Centre, Edinburgh, UK.; University of Toronto, Toronto, Canada.; Caldas C; University of Cambridge, Cambridge, UK.; Dunn J; University of Warwick, Coventry, UK.; Provenzano E; University of Cambridge, Cambridge, UK.; Sammut SJ; University of Cambridge, Cambridge, UK.; Thomas JS; Western General Hospital, Edinburgh, UK.; Graham A; Western General Hospital, Edinburgh, UK.; Hall P; Western General Hospital, Edinburgh, UK.; Mackintosh L; Western General Hospital, Edinburgh, UK.; Fan F; University of Kansas Medical Center, Kansas City, USA.; Godwin AK; University of Kansas Medical Center, Kansas City, USA.; Schwensen K; University of Kansas Medical Center, Kansas City, USA.; Sharma P; University of Kansas Medical Center, Kansas City, USA.; DeMichele AM; University of Pennsylvania, Philadelphia, USA.; Cole K; Yale University, New Haven, USA.; Pusztai L; Yale University, New Haven, USA.; Kim MO; University of California San Francisco, San Francisco, USA.; J van 't Veer L; University of California San Francisco, San Francisco, USA.; Cameron D; Western General Hospital, Edinburgh, UK.; Esserman LJ; University of California San Francisco, San Francisco, USA.; Fraser Symmans W; University of Texas MD Anderson Cancer Center, Houston, USA.

Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Kovacs T.; Rubio I. T.; Markopoulos C.; Audisio R. A.; Knox S.; Kuhn T.; Mansel R.; Matrai Z.; Meani F.; Nava M.; Wyld L.; Benn K.; Cardoso M. J.; Catanuto G.; Costa A.; Curigliano G.; Cserni G.; Downey S.; Farhadi J.; Gentilini O.; Gulluoglu B.; Herrero J. C.; Karakatsanis A.; Knauer M.; Kolacinska A.; Leidenius M.; McNeill F.; Museler S. B. L.; Poortmanns P.; Reyal F.; Sandelin K.; Morgan J.; Montagna G.; Wandschneider W.

European Journal of Surgical Oncology. 46:717-736

Gaillard T; Department Surgical Oncology, Institut Curie, Paris, France.; Institut Curie, Institut Hospitalo-Universitaire des Cancers des Femmes (ANR-23-IAHU-0006), Paris, France.; Beddok A; Department of Radiation Oncology, Institut Godinot, Reims, France.; Residual Tumor & Response to Treatment Laboratory, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.; Université de Reims Champagne-Ardenne, CRESTIC, Reims, France.; Baadj Y; Department Surgical Oncology, Institut Curie, Paris, France.; Institut Curie, Institut Hospitalo-Universitaire des Cancers des Femmes (ANR-23-IAHU-0006), Paris, France.; Feron JG; Department Surgical Oncology, Institut Curie, Paris, France.; Institut Curie, Institut Hospitalo-Universitaire des Cancers des Femmes (ANR-23-IAHU-0006), Paris, France.; Darrigues L; Department Surgical Oncology, Institut Curie, Paris, France.; Institut Curie, Institut Hospitalo-Universitaire des Cancers des Femmes (ANR-23-IAHU-0006), Paris, France.; Pauly L; Department Surgical Oncology, Institut Curie, Paris, France.; Institut Curie, Institut Hospitalo-Universitaire des Cancers des Femmes (ANR-23-IAHU-0006), Paris, France.; Grandal Rejo B; Department Surgical Oncology, Institut Curie, Paris, France.; Institut Curie, Institut Hospitalo-Universitaire des Cancers des Femmes (ANR-23-IAHU-0006), Paris, France.; Didelot H; Department Surgical Oncology, Institut Curie, Paris, France.; Institut Curie, Institut Hospitalo-Universitaire des Cancers des Femmes (ANR-23-IAHU-0006), Paris, France.; Van Coppenolle C; Department Surgical Oncology, Institut Curie, Paris, France.; Institut Curie, Institut Hospitalo-Universitaire des Cancers des Femmes (ANR-23-IAHU-0006), Paris, France.; Reyal F; Department Surgical Oncology, Institut Curie, Paris, France. fabien.reyal@curie.fr.; Department of Radiation Oncology, Institut Godinot, Reims, France. fabien.reyal@curie.fr.; Residual Tumor & Response to Treatment Laboratory, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France. fabien.reyal@curie.fr.; Institut Curie, Institut Hospitalo-Universitaire des Cancers des Femmes (ANR-23-IAHU-0006), Paris, France. fabien.reyal@curie.fr.; Laas E; Department Surgical Oncology, Institut Curie, Paris, France.; Institut Curie, Institut Hospitalo-Universitaire des Cancers des Femmes (ANR-23-IAHU-0006), Paris, France.

Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

Vincent, L. ; Jankowski, C. ; Arnould, L. ; Coudert, B. ; Rouzier, R. ; Reyal, F. ; Humbert, O. ; Coutant, C.

In Gynécologie Obstétrique Fertilité & Sénologie September 2020 48(9):679-686

Wyatt B; Institute for Research in bioMedicine and Epidemiology of Sport, Université Paris Cité, Paris, France.; INSEP (Institut National du Sport, de l'Expertise et de la Performance), Paris, France.; Forstmann N; Institute for Research in bioMedicine and Epidemiology of Sport, Université Paris Cité, Paris, France.; INSEP (Institut National du Sport, de l'Expertise et de la Performance), Paris, France.; Badier N; Institute for Research in bioMedicine and Epidemiology of Sport, Université Paris Cité, Paris, France.; INSEP (Institut National du Sport, de l'Expertise et de la Performance), Paris, France.; Hamy AS; Residual Tumor and Response to Treatment Laboratory, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Université Paris Cité, Paris, France.; De Larochelambert Q; Institute for Research in bioMedicine and Epidemiology of Sport, Université Paris Cité, Paris, France.; INSEP (Institut National du Sport, de l'Expertise et de la Performance), Paris, France.; Antero J; Institute for Research in bioMedicine and Epidemiology of Sport, Université Paris Cité, Paris, France.; INSEP (Institut National du Sport, de l'Expertise et de la Performance), Paris, France.; Danino A; Residual Tumor and Response to Treatment Laboratory, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Université Paris Cité, Paris, France.; Vercamer V; Withings, Issy-les-Moulineaux, France.; De Villele P; Withings, Issy-les-Moulineaux, France.; Vittrant B; Withings, Issy-les-Moulineaux, France.; Lanz T; Department of Anesthesiology, Clinique de la Sauvegarde, Lyon, France.; Reyal F; Residual Tumor and Response to Treatment Laboratory, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Université Paris Cité, Paris, France.; Department of Surgical Oncology, Institut Curie, Université Paris Cité, Paris, France.; Toussaint JF; Institute for Research in bioMedicine and Epidemiology of Sport, Université Paris Cité, Paris, France.; INSEP (Institut National du Sport, de l'Expertise et de la Performance), Paris, France.; CIMS (Center for Investigations in Medicine and Sports), Hôtel-Dieu, Assistance Publique - Hôpitaux de Paris, Paris, France.; Delrieu L; Institute for Research in bioMedicine and Epidemiology of Sport, Université Paris Cité, Paris, France.; INSEP (Institut National du Sport, de l'Expertise et de la Performance), Paris, France.; Residual Tumor and Response to Treatment Laboratory, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Université Paris Cité, Paris, France.

Publisher: JMIR Publications Country of Publication: Canada NLM ID: 100959882 Publication Model: Electronic Cited Medium: Internet ISSN: 1438-8871 (Electronic) Linking ISSN: 14388871 NLM ISO Abbreviation: J Med Internet Res Subsets: MEDLINE

Houvenaeghel, G. ; Cohen, M. ; Classe, J.M. ; Reyal, F. ; Mazouni, C. ; Chopin, N. ; Martinez, A. ; Daraï, E. ; Coutant, C. ; Colombo, P.E. ; Gimbergues, P. ; Chauvet, M.P. ; Azuar, A.S. ; Rouzier, R. ; Tunon de Lara, C. ; Muracciole, X. ; Agostini, A. ; Bannier, M. ; Charaffe Jauffret, E. ; De Nonneville, A. ; Goncalves, A.

In ESMO Open December 2021 6(6)

A-S Hamy; H Bonsang-Kitzis; D De Croze; E Laas; L Darrigues; L Topciu; E Menet; A Vincent-Salomon; F Lerebours; J-Y Pierga; E Brain; J-G Feron; G Benchimol; G-T Lam; M Laé; F Reyal

Cancer Research. 79:P3-11